Calendar Reviva Pharmaceuticals Holdings, Inc.

Equities

RVPH

US76152G1004

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
2.99 USD +0.34% Intraday chart for Reviva Pharmaceuticals Holdings, Inc. -0.99% -41.94%

Chart calendar Reviva Pharmaceuticals Holdings, Inc.

d3412bf96a6bfc8f3.sF_605OXuzXnpMkgbJ_mmc_lfVym3h7M_1Qihm7U8PQ.0QWogcb961GuzZ1nNu6cy7-9LS7l7n_9rDdTxQueyZDzB66_6tCNWYHnnA~0dc20c5f28ad7f8fa21038a709faef1b

Upcoming events on Reviva Pharmaceuticals Holdings, Inc.

12/05/2024 Q1 2024 Earnings Release (Projected)
11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
23/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Reviva Pharmaceuticals Holdings, Inc.

15/04/2024 13:05 Q4 2023 Earnings Release
04/04/2024 11:00 Schizophrenia International Research Society Meeting - Poster No : T291
04/04/2024 09:25 Schizophrenia International Research Society Meeting
27/03/2024 23:00 American Society for Clinical Pharmacology & Therapeutics Meeting
19/03/2024 21:00 Roth Conference
18/03/2024 17:30 UBS Virtual CNS Day
26/02/2024 19:45 BIO CEO & Investor Conference
15/02/2024 17:00 Investor Meeting - key Opinion Leader
01/02/2024 17:30 Lytham Partners Investor Select Conference - Fireside Chat
17/01/2024 20:00 Webull Live Virtual Healthcare Investment Conference
14/12/2023 17:00 Life Sciences Investor Forum
06/12/2023 Benchmark Company Discovery Conference
14/11/2023 21:01 Q3 2023 Earnings Release
13/11/2023 19:00 Annual General Meeting
30/10/2023 12:30 Phase 3 RECOVER Topline Results Conference Call
12/09/2023 20:30 H.C. Wainwright Global Investment Conference - Panel
11/09/2023 18:30 H.C. Wainwright Global Investment Conference
14/08/2023 21:01 Q2 2023 Earnings Release
10/08/2023 15:00 Canaccord Genuity Growth Conference
08/08/2023 19:00 BTIG Virtual Biotechnology Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-2,43
-2,33
-4.54%
-10,1
-10,4
3.12%
-24,3
-21,0
-15.56%
-39,5
-38,6
-2.22%

-39,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,78
-2,80
-35.14%
-8,52
-9,15
6.97%
-24,3
-20,8
-16.96%
-39,2
-37,5
-4.64%

-37,1

Net income
Million USD
Released
Forecast
Spread
-3,78
-2,80
-35.12%
-8,52
-9,16
6.98%
-24,3
-20,9
-16.41%
-39,3
-38,6
-1.75%

-37,1

EPS
USD
Released
Forecast
Spread
-1,24
-0,17
-629.41%
-0,58
-0,63
8.42%
-1,25
-1,09
-14.94%
-1,65
-1,58
-4.21%

-1,46

Announcement Date22/03/2115/03/2230/03/2315/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-3,96
-4,03
1.67%
-7,45
-4,49
-66.02%
-5,52
-6,64
16.85%
-3,56
-5,76
38.16%
-7,77
-4,50
-72.73%
-6,74
-7,35
8.4%
-12,1
-6,54
-84.51%
-10,7
-8,78
-22.01%
-9,99
-9,14
-9.33%

-10,1


-9,85


-10,8


-12,1


-13,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,68
-4,32
14.79%
-7,36
-4,49
-64.04%
-5,33
-6,64
19.65%
-3,51
-5,84
39.86%
-8,11
-4,33
-87.11%
-6,60
-7,30
9.63%
-12,4
-6,41
-94.1%
-10,5
-7,99
-31.09%
-9,73
-7,99
-21.71%

-10,2


-9,93


-10,8


-12,1


-13,6

Net income
Million USD
Released
Forecast
Spread
-3,68
-4,33
14.8%
-7,37
-4,49
-64.09%
-5,34
-6,64
19.54%
-3,52
-5,84
39.83%
-8,12
-4,33
-87.3%
-6,60
-7,30
9.59%
-12,4
-6,41
-94.16%
-10,5
-8,00
-31.21%
-9,72
-8,00
-21.63%

-10,2


-9,93


-10,8


-12,1


-13,6

EPS
USD
Released
Forecast
Spread
-0,22
-0,25
12%
-0,40
-0,25
-60%
-0,29
-0,35
17.14%
-0,18
-0,30
40%
-0,38
-0,22
-75.38%
-0,30
-0,31
1.64%
-0,55
-0,29
-89.66%
-0,44
-0,32
-36.65%
-0,35
-0,31
-12.9%

-0,37


-0,35


-0,36


-0,38


-0,42

Announcement Date15/03/2216/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2315/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RVPH Stock
  4. Calendar Reviva Pharmaceuticals Holdings, Inc.